During a time of much disruption to "business as usual" for the life sciences industry, this event focuses on the intersection of managing and maintaining
KOL engagement.
Even pre-COVID, this engagement was an area of significant importance that was constantly being tweaked based on regulatory guidance and industry best practices – but now that in-person/face to face meetings (including with your own internal teams) are no longer possible – the entire KOL playbook has changed.
With so many opinions, tech tools and tactics available, we look forward to bringing medical affairs/MSL's community together to take a deep dive into all aspects of working with KOLs in this challenging environment. Attendees will walk away with updates on how best map out their KOL strategy moving forward and new connections with industry colleagues facilitated through our advanced virtual event platform.
Top Reasons to Attend:
- Manage and maintain KOL engagement in our "new" normal, before, during and after a launch
- Establish best practices for working virtually with KOLs/advisory boards and learn new ways to keep an engaging relationship
- Know and understand the elements that facilitate productive relationships which leads to beneficial meetings with your thought leaders
- Approach digital transformation not only with KOLs but with DOLs (Digital Opinion Leaders), take a look at fresh and different ways to secure a successful interaction
- Enhance Teamwork between the Commercial and the Medical Affairs Teams to be on the same page while engaging their KOLs
Who Should Attend
- KOL Relationship Management/ Development
- Opinion/Thought Leader Relations
- Medical Science Liaison (MSL)
- Medical Affairs
- External Engagement
- Commercial Operations
- Medical and Professional Affairs/Strategy
- Medical and Professional Education
- Scientific/Medical Communication, Relations and Affairs
- Advisory Board Management
- Speaker Bureau Training/Management
- Speaker Programs
- Professional Education/Programs
- Global Relations
- Compliance, Legal and Regulatory
- CRM Systems
- External Affairs
- Stakeholder Relations/Outreach
- Medical Publications
- Physician Education/Outreach
- Promotional Regulatory Affairs
- Government Relations/Affairs
- Franchise/Business Unit/Therapeutic Area Management
- Brand/Portfolio Management
- Brand/Product Commercialization
- Commercial//Marketing Strategy
Networking Capabilities
- Virtual Matchmaking: Visit our virtual lobby and connect with fellow attendees using our platform's matchmaking technology. You can chat, video, and even make a list of the people you want to meet and the knowledge you're looking to gain through our bespoke 1:1 match-making services
- Roundtable Networking throughout the Summit will give you the chance to connect and meet in-depth your fellow attendees as well as our Sponsors and Speakers
- The platform we use allows us to make polls, QA, and chat during the sessions.
- Virtual Happy Hour: Grab a drink and bring it to your screen to cheers from afar while continuing to chat with and get to know your fellow conference participants.
Speakers
- Amy Pinelli, Regional Vice President, Business Partnerships - WITHIN3
- Dave Gulezian, CO-Founder & CEO - ALUCIO
- Kelley Dacus, Associate Director Medical Affairs - RECORDATI RARE DISEASES
- Kathleen Guindon, Senior Director MSL Team - QED THERAPEUTICS
- Vanessa Jacobsen, Executive Director, Medical Science Liaisons - NEKTAR THERAPEUTICS
- Ashish Dugar, Vice President Global Medical Affairs - SAREPTA THERAPEUTICS
- Alan Polnariev, Senior Medical Science Liaison - ASTRAZENECA
- Eddie Power, Vice President, North America Medical Affairs, Hospital Business - PFIZER
- Gabriel Smolarz, Medical Director Obesity - NOVO NORDISK
- Delinda Bane, Senior Manager, Medical Science Liaison, Medical Affairs, Parenteral Nutrition - FRESENIUS KABI
- Owen Muir, Founder and Chief Service Officer - BROOKLYN MINDS
- Jeff Sears, Associate Director, Commercial Communications - ASTELLAS PHARMA
- Barry Lubarsky, Executive Director, Medical Affairs Strategy - ALKERMES
- Jacqueline Armani, Regional MSL Lead - ALCON
- Oscar Segurado, Chief Medical Officer - ASC THERAPEUTICS
- Sudeesh Tantry, Vice President, Global Medical Affairs - GLENMARK PHARMACEUTICALS
- Merideth Rodgers, Medical Director - REGENERON PHARMACEUTICALS
- Bryan Bischel, Field Director, Hepatology - MALLINCKRODT PHARMACEUTICALS
- Kevin Wu, Senior Medical Director, Global Medicines Development Immunotherapy - ASTRAZENECA
- Caroline Ojaimi, Director - Oncology, Medical Affairs, Strategy and Operations - EISAI
- Howard Berkowitz, Respiratory and Immunology Medical Science Liaison - SANOFI GENZYME
- Courtney Zeni, Director, Medical Affairs - SUNOVION PHARMACEUTICALS
Please fill in your name and email to receive the Virtual Agenda of this event.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
